ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.704,42
-0,11%
S&P 500
5.303,27
0,12%
Dow Jones
40.003,59
0,34%
Euro vs US Dollar
1,08905
-0,04%
Bitcoin
67.028,82
0,13%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Bivictrix Therapeutics Plc (BVX)

  7. Bivictrix Therapeutics Plc (BVX) News

BVX

Bivictrix Therapeutics (BVX)

Bivictrix Therapeutics Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:BVX
DatumZeitQuelleÜberschriftSymbolFirma
17/04/202415h23Alliance NewsAlliance NewsBivictrix granted FDA orphan drug status for rare cancer treatmentLSE:BVXBivictrix Therapeutics Plc
17/04/202408h00RNS Regulatory NewsBiVictriX Therapeutics PLC Orphan Drug Designation & FDA INTERACT MeetingLSE:BVXBivictrix Therapeutics Plc
28/03/202408h00RNS Regulatory NewsBiVictriX Therapeutics PLC Grant of Options – PDMR/Director DealingsLSE:BVXBivictrix Therapeutics Plc
04/01/202413h30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
04/01/202413h30UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
04/01/202408h00UK RegulatoryBiVictriX Therapeutics PLC BiVictriX Hosts Inaugural Roundtable DiscussionLSE:BVXBivictrix Therapeutics Plc
05/12/202312h08UK RegulatoryBiVictriX Therapeutics PLC Board ChangeLSE:BVXBivictrix Therapeutics Plc
30/11/202313h08Alliance NewsAlliance NewsIN BRIEF: Bivictrix selects final sequences for lead tumour programmeLSE:BVXBivictrix Therapeutics Plc
30/11/202308h00UK RegulatoryBiVictriX Therapeutics PLC Pipeline update on BVX002LSE:BVXBivictrix Therapeutics Plc
22/11/202318h14UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
15/11/202314h05Alliance NewsAlliance NewsTRADING UPDATES: BiVictriX patent boost; 4Global deal extendedLSE:BVXBivictrix Therapeutics Plc
15/11/202308h00UK RegulatoryBiVictriX Therapeutics PLC Patent Granted in JapanLSE:BVXBivictrix Therapeutics Plc
12/10/202313h04Alliance NewsAlliance NewsBivictrix says BVX001 increases survival rates by more than doubleLSE:BVXBivictrix Therapeutics Plc
12/10/202308h00UK RegulatoryBiVictriX Therapeutics PLC Extended Survival Rates Reported with BVX001LSE:BVXBivictrix Therapeutics Plc
03/10/202313h06Alliance NewsAlliance NewsBivictrix hires new CFO as Alex Hughes steps down after seven monthsLSE:BVXBivictrix Therapeutics Plc
03/10/202308h00UK RegulatoryBiVictriX Therapeutics PLC Appointment of Adrian Howd as CFO and CBOLSE:BVXBivictrix Therapeutics Plc
19/09/202318h30Alliance NewsAlliance NewsTRADING UPDATES: AEW UK REIT appoints new chair; Oberon raises moneyLSE:BVXBivictrix Therapeutics Plc
19/09/202308h00UK RegulatoryBiVictriX Therapeutics PLC Interim ResultsLSE:BVXBivictrix Therapeutics Plc
31/08/202308h00UK RegulatoryBiVictriX Therapeutics PLC Total Voting RightsLSE:BVXBivictrix Therapeutics Plc
23/08/202310h30Alliance NewsAlliance NewsBivictrix Therapeutics granted US patent for cancer drug BVX001LSE:BVXBivictrix Therapeutics Plc
23/08/202308h00UK RegulatoryBiVictriX Therapeutics PLC US Patent GrantedLSE:BVXBivictrix Therapeutics Plc
17/08/202308h00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
16/08/202319h00UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
11/08/202317h17UK RegulatoryBiVictriX Therapeutics PLC Holding(s) in CompanyLSE:BVXBivictrix Therapeutics Plc
08/08/202318h18UK RegulatoryBiVictriX Therapeutics PLC Result of General MeetingLSE:BVXBivictrix Therapeutics Plc
19/07/202320h30Alliance NewsAlliance NewsUPDATE: Bivictrix Therapeutics raises GBP2.1 million through fundraiseLSE:BVXBivictrix Therapeutics Plc
19/07/202319h16UK RegulatoryBiVictriX Therapeutics PLC Result of Conditional FundraiseLSE:BVXBivictrix Therapeutics Plc
19/07/202315h12Alliance NewsAlliance NewsIN BRIEF: Bivictrix to raise more than GBP2 million via placingLSE:BVXBivictrix Therapeutics Plc
19/07/202313h31UK RegulatoryBiVictriX Therapeutics PLC Proposed Fundraise in excess of GBP2 millionLSE:BVXBivictrix Therapeutics Plc
17/07/202314h57Alliance NewsAlliance NewsBivictrix Therapeutics hails positive data in final leukaemia studyLSE:BVXBivictrix Therapeutics Plc
 Showing the most relevant articles for your search:LSE:BVX

Kürzlich von Ihnen besucht

TSXV
FE
USOTC
CRDIY
Concordia Financial (PK)
AMEX
HDP.U
NYSE
GEF.B
Greif
EU
RBBV
EMTN Regbrfrn19oct32
LSE
TPJ
Triple Plate Junction
EU
BEAR00563419
Euronext VPU Public auct...
ASX
GEMKOD
LSE
IEGE
Ishr E Gov 0-1
BIT
UB8PD2
Unicredit Bank
COIN
FTDUST
ForTheDog
EU
QEVT
SPEAR Investments
BOV
R2BL34Q
Roblox
TSXV
GFA
BIT
F18489
Vontobel Financial Produ...
NASDAQ
DISCB
Discovery
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten